METHODS OF DETERMINATION OF ACTIVATION OR INACTIVATION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AND BRAIN NATRIURETIC PEPTIDE (BNP) HORMONAL SYSTEMS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14841863

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An in vivo method of determining activation or inactivation of the atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems, the method comprising simultaneously detecting the presence or amount of atrial and brain natriuretic peptide prohormones (proANP and proBNP) or fragments thereof in a sample.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ORION DIAGNOSTICA OY02200 ESPOO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ALA-KOPSALA, Minna Oulu, FI 3 8
HAAPALAHTI, Jouko Kempele, FI 3 8
LEPPÄLUOTO, Juhani Oulu, FI 7 44
RUSKOAHO, Heikki Tyrnava, FI 3 8
VUOLTEENAHO, Olli Oulu, FI 3 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation